C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Complement component 5a receptor 1 (C5AR1) or CD88 is a G protein-coupled receptor for C5a. It functions as a complement receptor. Receptor activation stimulates chemotaxis, granule enzyme release, intracellular calcium release and superoxide anion production.

The C5a Anaphylatoxin Chemotactic Receptor 1 pipeline market research report provides comprehensive information on the therapeutics under development for Complement component 5a receptor 1, complete with analysis by stage of development, drug therapy areas, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases.

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Segmentation by Therapy Areas

The key therapy areas in the C5AR1 pipeline products market are immunology, central nervous system, gastrointestinal, dermatology, genito urinary system and sex hormones, hematological disorders, infectious disease, mouth and dental disorders, musculoskeletal disorders, oncology, and respiratory.

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Analysis by Therapy Areas, 2022 (%)

For more therapy area insights into the C5a Anaphylatoxin Chemotactic Receptor 1 pipeline products market, download a free report sample

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Segmentation by Mechanisms of Action

The key mechanisms of action in the C5AR1 pipeline products market are C5a Anaphylatoxin Chemotactic Receptor 1 Antagonist, and C5a Anaphylatoxin Chemotactic Receptor 1 Agonist.

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Analysis by Mechanisms of Action, 2022 (%)

For more mechanisms of action insights into the C5a Anaphylatoxin Chemotactic Receptor 1 pipeline products market, download a free report sample

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Segmentation by Routes of Administration

The key routes of administration in the C5AR1 pipeline products market are oral, subcutaneous, and intravenous.

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Analysis by Routes of Administration, 2022 (%)

For more routes of administration insights into the C5a Anaphylatoxin Chemotactic Receptor 1 pipeline products market, download a free report sample

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Segmentation by Molecule Types

The key molecule types in the C5AR1 pipeline products market are synthetic peptide, monoclonal antibody, and small molecule.

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Analysis by Molecule Types, 2022 (%)

For more molecule type insights into the C5a Anaphylatoxin Chemotactic Receptor 1 pipeline products market, download a free report sample

Competitive Landscape

Some of the leading companies in the C5AR1 pipeline products market are Alsonex Pty Ltd, ChemoCentryx Inc, Dompe Farmaceutici SpA, InflaRx NV, Innate Pharma SA, MorphoSys AG.

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Analysis by Companies, 2022 (%)

To know more about the leading companies in the C5a Anaphylatoxin Chemotactic Receptor 1 pipeline products market, download a free report sample

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Report Overview

Segments Covered in the Report

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Therapy Areas Outlook

• Immunology
• Central Nervous System
• Gastrointestinal
• Dermatology
• Genito Urinary System And Sex Hormones
• Hematological Disorders
• Infectious Disease
• Mouth And Dental Disorders
• Musculoskeletal Disorders
• Oncology
• Respiratory

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Mechanisms of Action Outlook

• C5a Anaphylatoxin Chemotactic Receptor 1 Antagonist
• C5a Anaphylatoxin Chemotactic Receptor 1 Agonist

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Routes of Administration Outlook

• Oral
• Subcutaneous
• Intravenous

C5a Anaphylatoxin Chemotactic Receptor 1 Pipeline Products Market Molecule Type Outlook

• Synthetic Peptide
• Monoclonal Antibody
• Small Molecule

Scope

• The report provides a snapshot of the global therapeutic landscape for C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1)
• The report reviews C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) targeted therapeutics and enlists all their major and minor projects
• The report assesses C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news and deals related to C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) targeted therapeutics

Reasons to Buy

• Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand the targeted therapy areas and indications for C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1)Identify the use of drugs for target identification and drug repurposing
• Identify potential new clients or partners in the target demographic
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
• Devise corrective measures for pipeline projects by understanding C5a Anaphylatoxin Chemotactic Receptor 1 (CD88 or C5AR1) development landscape
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope